Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion group

Author:

Uchiyama Asako1,Naritomi Yoichi2,Hashimoto Yoshitaka3,Hanada Takeshi4,Watanabe Kyoko4,Kitta Kumiko5,Suzuki Genki6,Komatsuno Takao7,Nakamura Takahiro1

Affiliation:

1. Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd, 2438 Miyanouracho, Kagoshima, Japan

2. Research Division, Healios K.K., 1-5-2 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo, Japan

3. Translational Research Laboratories, Ono Pharmaceutical Co., Ltd, 3-1-1 Sakurai Shimamoto-Cho, Mishima-Gun, Osaka, Japan

4. Drug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, Japan

5. Bioresearch Center, CMIC Pharma Science Co., Ltd, 10221 Kobuchisawa-cho, Hokuto-shi, Yamanashi, Japan

6. Bioanalysis Department, Advanced Technology Center, LSI Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, Japan

7. Drug Discovery Department, Center for Research & Chemistry, Manufacturing & Controls, AnGes, Inc., 4-13-3 Shiba, Minato-ku, Tokyo, Japan

Abstract

Investigating the biodistribution of cell and gene therapy products may play an important role in evaluating their safety and pharmacology. As quantitative polymerase chain reaction (qPCR) is often used for these analyses, it is essential to improve the reliability of bioanalysis performed using qPCR. In this report, the authors discuss the use of qPCR in nonclinical studies, as it can be used to detect target DNA/RNA and it is quantitative and applicable for long-term analysis. The authors also discuss points to consider during bioanalysis using qPCR and present appropriate validation items and their criteria. The authors anticipate the discussion provided herein to contribute to the development of validation and sample analysis for pharmaceuticals analyzed using qPCR.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Reference61 articles.

1. Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells

2. European Medicines Agency. Guideline on bioanalytical method validation (2011). www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf

3. Japanese Ministry of Health, Labor and Welfare. Guideline on bioanalytical method validation in pharmaceutical development (2013). www.pmda.go.jp/files/000206209.pdf

4. Japanese Ministry of Health, Labor and Welfare. Guideline on bioanalytical method (ligand binding assay) validation in pharmaceutical development (2014). www.pmda.go.jp/files/000206208.pdf

5. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for industry: bioanalytical method validation (2018). www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3